Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.
about
Plant Viruses as Nanoparticle-Based Vaccines and AdjuvantsBiomimetic and synthetic interfaces to tune immune responsesSynthetic Nanoparticles for Vaccines and ImmunotherapyAdvances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public HealthAnalysis of human innate immune responses to PRINT fabricated nanoparticles with cross validation using a humanized mouse modelAntigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding.Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccinationAntigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccineBiomaterials for nanoparticle vaccine delivery systems.A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputsAnalysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery.Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavity.Homeopathic medications as clinical alternatives for symptomatic care of acute otitis media and upper respiratory infections in children.Particle based vaccine formulations for transcutaneous immunizationIntegrative nanomedicine: treating cancer with nanoscale natural products.Engaging adaptive immunity with biomaterialsRecruitment of bone marrow CD11b+Gr-1+ cells by polymeric nanoparticles for antigen cross-presentation.Peptide/protein vaccine delivery system based on PLGA particles.Lipid-enveloped hybrid nanoparticles for drug delivery.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Engineering synthetic vaccines using cues from natural immunity.Invariant NKT cells provide innate and adaptive help for B cells.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy.Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.Biomimetically Engineered Demi-Bacteria Potentiate Vaccination against Cancer.The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.Optimization and comparison of CD4-targeting lipid-polymer hybrid nanoparticles using different binding ligands.Nanoparticle Vaccines Against Infectious DiseasesCo-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses
P2860
Q26782569-F9459A1C-BBB0-490B-9A5D-27A345387F01Q26801229-63811197-A963-4DB8-8946-08830968AE24Q28085375-EEB8B440-054F-43A7-8354-F990A3112A3EQ28384520-24BD6315-D234-40BA-B13B-D543382A89E7Q28391210-7F4ECBB1-500C-474C-8BDA-A7BAB9A27CCDQ33972302-5F52F764-747D-450A-B463-3260D33AF07EQ34074750-5169FA26-3128-4CC1-90E1-3CCF241EAED6Q34157315-95026902-BB98-4404-A93C-54881CE8E0D9Q34345012-44DBF365-01B5-4ED2-8D42-26ED5A1AB5C8Q34454233-757EFEE0-7F6F-48FB-A7C4-5D3F005237F5Q34490296-B8E638E1-9D21-4DF4-8DD2-2161E93F2C87Q34675068-0C5ED892-FCF3-43FA-B5CB-D5EA7E423148Q35836140-F792B187-6A11-4299-BF85-F9B22BD4DDD9Q35983565-F9CD77A6-3061-43EC-84B1-7D230113AADCQ36052188-43AFD48E-CBF7-4F6C-A68F-B5501FB11B0CQ36726849-87C5C5F3-6EA3-43FA-B680-461C6FD3089EQ36920308-585DB5D9-0321-4B64-8F23-3B5E450ED509Q37324073-6102D2EB-E458-4CDE-98A5-77CA4BD1A2C1Q37530378-943EE3EC-F551-4BE2-BC7D-5CBA9FB297F4Q37578847-F0FA55EE-2796-410E-A20E-99671785B0BCQ37691850-1D2BE4C1-013A-4D79-8BE7-A87E065BFF66Q37710630-E8C24DE3-B017-4682-AE4F-6E242A84E6FCQ37838652-3DD63985-661D-4855-830A-B935AE315A82Q38071910-92F2F929-94EA-431F-843E-EDF1BD1B646DQ38150118-E3849193-24A9-4E46-B056-60E476E31656Q38154804-62BEA845-0366-4CCC-96DD-899B76257291Q38186944-DF6604C2-5617-4650-BC1B-6024A919D7F5Q38418305-6B6EDBC6-A1F7-46A2-A707-01A71B497F08Q38564323-0B538511-F685-4D43-953F-6DC4BB55EF3CQ38912004-62420384-2D69-45A6-9849-AD3E160F067EQ39780595-DC369969-210F-408A-B58B-D7B889E3ABBCQ40000942-F9E55FEC-D1FC-41D1-9A0C-04D279B6B65BQ42379305-A1FBFEC7-C22E-4CD9-A752-B4E6ECFC7EACQ42926219-EEC8787D-0AE6-4D71-A6F6-660B43CEF657Q47137438-500478C8-C412-405D-BE70-BAD8108F8B99Q47225568-257CE078-DFAA-4DCC-9DA2-5777EAFF4EDFQ58583890-0183715B-B49C-46DC-A96F-E003E62A9105Q58791545-FCA1540F-2E3E-4A34-B925-AF0A998BC5BA
P2860
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Robust IgG responses to nanogr ...... lipid-coated particle vaccine.
@ast
Robust IgG responses to nanogr ...... lipid-coated particle vaccine.
@en
type
label
Robust IgG responses to nanogr ...... lipid-coated particle vaccine.
@ast
Robust IgG responses to nanogr ...... lipid-coated particle vaccine.
@en
prefLabel
Robust IgG responses to nanogr ...... lipid-coated particle vaccine.
@ast
Robust IgG responses to nanogr ...... lipid-coated particle vaccine.
@en
P2093
P2860
P1476
Robust IgG responses to nanogr ...... lipid-coated particle vaccine
@en
P2093
Adrienne V Li
Anna Bershteyn
Darrell J Irvine
Heikyung Suh
James J Moon
Monica P Crespo
P2860
P304
P356
10.1016/J.JCONREL.2011.07.029
P407
P577
2011-07-24T00:00:00Z